Research
A common osteoporosis drug blocked spinal damage in a surprising new study
The Brief
- Researchers identified a genetic connection to spinal degeneration.
- An existing osteoporosis drug prevented damaging mineral buildup in zebrafish spines.
- The findings could pave the way for new treatments that slow or prevent a major cause of spinal degeneration.
Why it matters
It suggests an already-approved osteoporosis drug may be worth testing against spinal degeneration, though these sources report results only in zebrafish, not humans.
Who’s affected
- researchers in bone and spine biology
- clinicians who treat spinal degeneration
- #spinal degeneration
- #osteoporosis
- #zebrafish
- #drug repurposing
- #genetics
- #bone health
Scientists have uncovered a surprising genetic connection to spinal degeneration and found that an existing osteoporosis drug can prevent damaging mineral buildup in zebrafish spines. The discovery could pave the way for new treatments that slow or prevent a major cause of…